Heterogeneity and lack of standardisation in gut microbiome testing: a comparative assessment of French medical biology laboratories - Report - MDSpire

Heterogeneity and lack of standardisation in gut microbiome testing: a comparative assessment of French medical biology laboratories

  • By

  • Maxime Pichon

  • Claire Bouleti

  • MICMAC Study Group SFM

  • Genevieve Hery-Arnaud

  • Christophe Burucoa

  • July 1, 2026

  • 0 min

Share

Clinical Report: Variability and Absence of Standardization in Gut Microbiome Testing

Overview

This study evaluates the methods and results of microbiome testing across five French laboratories, revealing significant variability and a lack of standardization, which raises concerns about the scientific validity and clinical interpretability of these tests. Such issues may mislead consumers and healthcare providers, necessitating urgent action.

Background

The human gut microbiome is crucial for health and disease management, yet the rise in consumer interest in microbiome testing has outpaced the scientific validation of these products. This study addresses the urgent need for standardization and regulatory oversight in microbiome testing to ensure reliable and clinically useful results, particularly in managing conditions like IBS and obesity.

Data Highlights

Qualitative findings indicate significant discrepancies in testing methodologies and report interpretations across laboratories.

Key Findings

Key findings include significant heterogeneity in microbiome testing kits across laboratories, variations in report lengths from 9 to 36 pages, and contradictory interpretations of microbiome health status, which could impact patient care.

Clinical Implications

Healthcare providers should approach microbiome testing results with caution, ensuring they verify the credibility of sources and consider the lack of standardization when interpreting results. Enhanced regulatory measures and education on microbiome science are essential for improving test reliability and clinical utility.

Conclusion

The study underscores the critical need for coordinated efforts among regulators, industry, and academia to enhance the reliability of microbiome diagnostics and protect patient health, emphasizing the importance of establishing clear standards.

Related Resources & Content

  1. de Vos et al., The Journal of Infectious Diseases, 2024 -- Variability and Absence of Standardization in Gut Microbiome Testing
  2. Associated Press Health, 2024 -- Discover the power of gut microbiome tests for wellness and longevity
  3. The New Gastroenterologist, 2025 -- Innovative Fecal Sample Developed to Advance Microbiome Studies
  4. International consensus statement on microbiome testing in clinical practice - PMC, 2024
  5. Critical Care (Springer) — The Real-World Effects of Clinical Metagenomics in Intensive Care Settings: A Retrospective Multicenter Analysis from Hospitals in the Greater Paris Region
  6. Nature Medicine, 2026 -- The Real-World Effects of Clinical Metagenomics in Intensive Care Settings
  7. Evaluating the analytical performance of direct-to-consumer gut microbiome testing services | Communications Biology
  8. International consensus statement on microbiome testing in clinical practice - PMC

Original Source(s)

Related Content